Comparison of Two Treatment Regimens (Sitagliptin Versus Liraglutide) on Participants Who Failed to Achieve Good Glucose Control on Metformin Alone (MK-0431-403)

NCT01296412 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

653

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: sitagliptin
DRUG: liraglutide
DRUG: glimepiride
DRUG: metformin

Sponsor

Merck Sharp & Dohme LLC